Stem Cells Spin S.A. (WSE:SCS)

Poland · Delayed Price · Currency is PLN

0.4680

-0.0020 (-0.43%)

At close: Aug 25, 2026

18.18% (1Y)

Market Cap	19.35M +18.2%
Revenue (ttm)	58.47K -29.5%
Net Income	-591.31K
EPS	-0.01
Shares Out	41.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	0.4700
Previous Close	0.4700
Day's Range	0.4680 - 0.4700
52-Week Range	0.2800 - 0.5400
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and usage of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wrocław, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O. [Read more]

Industry Biotechnology & Medical Research

Sector Healthcare

Founded 2009

Employees 1

Stock Exchange Warsaw Stock Exchange

Ticker Symbol SCS

Full Company Profile

Financial Performance

In 2025, Stem Cells Spin's revenue was 65,736, an increase of 21.11% compared to the previous year's 54,280. Losses were -525,624, 1.03% more than in 2024.

Financial Statements